Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders

Author： Hayashi Teruo Tsai Shang-Yi Mori Tomohisa Fujimoto Michiko Su Tsung-Ping

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.5, 2011-05, pp. : 557-577

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

-1 Receptor Ligands: Potential in the Treatment of Neuropsychiatric Disorders

By Hayashi T. Su T-P.

CNS Drugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 269-284

Adis International

Access to resources Recommend Favorite

An update on the development of drugs for neuropsychiatric disorders: focusing on the σ₁ receptor ligand

By Hayashi Teruo Su Tsung-Ping

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 1, 2008-01 ,pp. : 45-58

Informa Healthcare

Access to resources Recommend Favorite

Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders

By Vinod K Yaragudri Hungund Basalingappa L

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 203-210

Informa Healthcare

Access to resources Recommend Favorite

Commentary [Targeting Opioid Receptors: A New Treatment for Brain Disorders]

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 128-128

Bentham Science Publishers

Access to resources Recommend Favorite

Sigma-1 Receptors: Potential Targets for the Treatment of Substance Abuse

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 902-919

Bentham Science Publishers

Access to resources Recommend Favorite